The general PBS co-payment reduction will cost companies over $90 million over the next four years and around $30 million each year after that on an ongoing basis. …
Companies face higher rebate payments as a result of co-pay reduction
July 31, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Trump administration takes another step in 'Most Favored Nation' push
August 1, 2025 - - Latest News -
Arrotex expands haematology-oncology portfolio through Antengene partnership
August 1, 2025 - - Latest News -
Study reveals growing benefit of Lilly therapy for early symptomatic Alzheimer’s disease
August 1, 2025 - - Latest News -
Novartis backs the launch of a new cardiovascular disease program
August 1, 2025 - - Latest News -
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 - - Latest News -
AusBiotech and Medicines Australia celebrate Catalyst outcomes and further strengthen industry collaboration
August 1, 2025 - - Latest News -
AbbVie therapy now available on the PBS for treatment of advanced Parkinson’s
August 1, 2025 - - Latest News